IDH2 and glioblastoma: Data derived mainly from astrocytoma patients suggest an inverse relationship, with higher CCT expression predominantly observed in IDH-wild-type tumors [103]; in contrast, studies on glioblastoma have not specifically linked CCT overexpression to IDH mutation status [48].